Federated Hermes’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $603M | Buy |
21,476,961
+1,229,080
| +6% | +$32.7M | 0.98% | 12 |
|
|
2025
Q4 | $504M | Buy |
20,247,881
+1,641,421
| +9% | +$41.4M | 0.84% | 16 |
|
|
2025
Q3 | $474M | Sell |
18,606,460
-512,479
| -3% | -$12.6M | 0.84% | 20 |
|
|
2025
Q2 | $463M | Buy |
19,118,939
+1,526,230
| +9% | +$35.6M | 0.87% | 13 |
|
|
2025
Q1 | $446M | Buy |
17,592,709
+3,201,087
| +22% | +$83.8M | 0.96% | 13 |
|
|
2024
Q4 | $382M | Sell |
14,391,622
-601,995
| -4% | -$16.3M | 0.84% | 15 |
|
|
2024
Q3 | $434M | Buy |
14,993,617
+70,072
| +0.5% | +$2.04M | 0.95% | 10 |
|
|
2024
Q2 | $418M | Buy |
14,923,545
+470,003
| +3% | +$12.9M | 0.99% | 12 |
|
|
2024
Q1 | $401M | Buy |
14,453,542
+1,105,604
| +8% | +$30.7M | 0.92% | 12 |
|
|
2023
Q4 | $384M | Sell |
13,347,938
-781,269
| -6% | -$23.6M | 0.95% | 13 |
|
|
2023
Q3 | $469M | Sell |
14,129,207
-1,494,153
| -10% | -$52.8M | 1.25% | 8 |
|
|
2023
Q2 | $573M | Buy |
15,623,360
+2,399,603
| +18% | +$93.4M | 1.42% | 7 |
|
|
2023
Q1 | $540M | Buy |
13,223,757
+4,249,987
| +47% | +$184M | 1.36% | 7 |
|
|
2022
Q4 | $460M | Buy |
8,973,770
+1,602,318
| +22% | +$76.8M | 1.27% | 7 |
|
|
2022
Q3 | $323M | Buy |
7,371,452
+24,752
| +0.3% | +$1.2M | 0.95% | 15 |
|
|
2022
Q2 | $385M | Buy |
7,346,700
+703,529
| +11% | +$35.9M | 1.05% | 11 |
|
|
2022
Q1 | $344M | Buy |
6,643,171
+2,091,343
| +46% | +$109M | 0.78% | 16 |
|
|
2021
Q4 | $269M | Sell |
4,551,828
-1,942,179
| -30% | -$96.2M | 0.5% | 32 |
|
|
2021
Q3 | $279M | Sell |
6,494,007
-6,226,238
| -49% | -$276M | 0.53% | 28 |
|
|
2021
Q2 | $498M | Buy |
12,720,245
+815,508
| +7% | +$31.7M | 0.93% | 11 |
|
|
2021
Q1 | $431M | Sell |
11,904,737
-369,328
| -3% | -$13.1M | 0.84% | 12 |
|
|
2020
Q4 | $452M | Sell |
12,274,065
-1,719,570
| -12% | -$63.1M | 0.92% | 12 |
|
|
2020
Q3 | $487M | Sell |
13,993,635
-193,003
| -1% | -$6.77M | 1.14% | 9 |
|
|
2020
Q2 | $440M | Sell |
14,186,638
-3,546,612
| -20% | -$120M | 1.09% | 12 |
|
|
2020
Q1 | $549M | Sell |
17,733,250
-898,718
| -5% | -$30.6M | 1.61% | 7 |
|
|
2019
Q4 | $693M | Buy |
18,631,968
+6,473,885
| +53% | +$231M | 1.54% | 7 |
|
|
2019
Q3 | $414M | Buy |
12,158,083
+6,701,841
| +123% | +$244M | 1.02% | 16 |
|
|
2019
Q2 | $224M | Buy |
5,456,242
+4,309,779
| +376% | +$171M | 0.54% | 27 |
|
|
2019
Q1 | $46.2M | Buy |
1,146,463
+118,351
| +12% | +$4.74M | 0.11% | 202 |
|
|
2018
Q4 | $42.6M | Sell |
1,028,112
-4,974,127
| -83% | -$206M | 0.12% | 189 |
|
|
2018
Q3 | $251M | Sell |
6,002,239
-599,582
| -9% | -$23.1M | 0.59% | 30 |
|
|
2018
Q2 | $227M | Buy |
6,601,821
+3,464,896
| +110% | +$118M | 0.67% | 26 |
|
|
2018
Q1 | $106M | Sell |
3,136,925
-528,296
| -14% | -$18.2M | 0.31% | 66 |
|
|
2017
Q4 | $126M | Buy |
3,665,221
+631,322
| +21% | +$21.5M | 0.36% | 53 |
|
|
2017
Q3 | $103M | Buy |
3,033,899
+112,958
| +4% | +$3.63M | 0.29% | 65 |
|
|
2017
Q2 | $93.1M | Sell |
2,920,941
-121,261
| -4% | -$3.82M | 0.27% | 66 |
|
|
2017
Q1 | $98.7M | Buy |
3,042,202
+362,167
| +14% | +$11.4M | 0.28% | 65 |
|
|
2016
Q4 | $82.6M | Sell |
2,680,035
-82,214
| -3% | -$2.51M | 0.25% | 72 |
|
|
2016
Q3 | $88.8M | Sell |
2,762,249
-1,581,544
| -36% | -$52.9M | 0.26% | 71 |
|
|
2016
Q2 | $145M | Sell |
4,343,793
-888,402
| -17% | -$28.4M | 0.42% | 43 |
|
|
2016
Q1 | $147M | Buy |
5,232,195
+1,276,772
| +32% | +$36.5M | 0.46% | 40 |
|
|
2015
Q4 | $121M | Buy |
3,955,423
+275,971
| +8% | +$8.68M | 0.38% | 55 |
|
|
2015
Q3 | $110M | Sell |
3,679,452
-536,830
| -13% | -$17.2M | 0.35% | 58 |
|
|
2015
Q2 | $134M | Sell |
4,216,282
-1,272,408
| -23% | -$41.5M | 0.4% | 51 |
|
|
2015
Q1 | $181M | Sell |
5,488,690
-401,024
| -7% | -$12.7M | 0.55% | 33 |
|
|
2014
Q4 | $174M | Sell |
5,889,714
-15,681
| -0.3% | -$450K | 0.54% | 36 |
|
|
2014
Q3 | $166M | Buy |
5,905,395
+313,435
| +6% | +$8.8M | 0.53% | 38 |
|
|
2014
Q2 | $157M | Sell |
5,591,960
-536,317
| -9% | -$15.3M | 0.49% | 38 |
|
|
2014
Q1 | $187M | Sell |
6,128,277
-1,529,978
| -20% | -$45.6M | 0.62% | 30 |
|
|
2013
Q4 | $223M | Buy |
7,658,255
+18,746
| +0.2% | +$546K | 0.77% | 24 |
|
|
2013
Q3 | $208M | Buy |
7,639,509
+157,233
| +2% | +$4.28M | 0.8% | 23 |
|
|
2013
Q2 | $199M | Buy |
+7,482,276
| New | +$207M | 0.79% | 24 |
|
Other funds holding PFE
VCM
VPM
Federated Hermes's PFE Position: Q1 2026 in Review
Federated Hermes increased its Pfizer (PFE) stake by 6.1% in Q1 2026, buying an estimated $32.7M and bringing the position to 21,476,961 shares worth $603M. The position accounts for 0.98% of the portfolio, ranked #12.
Federated Hermes first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $693M in Q4 2019. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Federated Hermes held 21,476,961 shares of Pfizer worth $603M as of Q1 2026.
- Federated Hermes bought 1,229,080 Pfizer shares in Q1 2026, an estimated $32.7M.
- Pfizer made up 0.98% of Federated Hermes's portfolio in Q1 2026, its #12 holding.
- Federated Hermes first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Pfizer position peaked at $693M in Q4 2019.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.